medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2015, Number 3

<< Back

Acta Med Cent 2015; 9 (3)

Hiperintensidades de la sustancia blanca en resonancia magnética, ¿un reto su interpretación?

Rodríguez MJL

Language: Spanish
References: 71
Page: 68-84
PDF size: 464.36 Kb.


ABSTRACT

It is a serious diagnosis problem in Specialty of Imaging, viewing images that light (hyperintense) in contrasting techniques T2 and the suppression sequence of cerebrospinal fluid, known in the literature as unidentified bright object and displaying hyperintense larger plates with or without specific clinical symptoms. A review of patterns of hyperintense brain imaging is made for better interprataion, based on knowledge of the anatomy of the cerebral microcirculation and its interstice, and thus approaching the condition of the white matter to consider what elements are most affected in different groups of leukoencephalopathies and recognize its main findings and exceptions in the presentation during the magnetic resonance studies.


REFERENCES

  1. Iosifescu DV, Papakostas GI, Lyoo IK. Hiperintensidades de la Sustancia Blanca en la Resonancia Magnética Nuclear Cerebral y Metabolismo de Restos Monocarbonados en Pacientes Ambulatorios no Geriátricos con Trastorno Depresivo Mayor (Parte I). Psychiatry Res Neuroimag. 2005;140(3):291-99.

  2. Marin-Padilla M. The human brain intracerebral microvascular system: development and structure. Front Neuroanat. 2012;6:38.

  3. Marín-Padilla M. El cerebro del niño: desarrollo normal (no alterado) y alterado por daño perinatal. Rev Neurol. 2013;57(Supl 1):S3-15.

  4. Marin-Padilla M, Tsai R, King MA, Roper SN. Altered corticogenesis and neuronal morphology in irradiation-induced cortical dysplasia and epilepsy. A Golgi study. J Neuropathol Exp Neurol. 2003 Nov;62(11):1129-43.

  5. Ferrer I, Soriano E, Del Río J. Cell death and removal in the cerebral cortex during development. Progr Neurobiol. 1992;39:1-43.

  6. Smith EE, Eichler FS, Filley CM. Cerebral White Matter. Ann N Y Acad Sci. 2008 Oct;1142:266–309.

  7. Tirapu-Ustárroz J, Luna-Lario P, Hernáez-Goñi P, García-Suescun I. Relación entre la sustancia blanca y las funciones cognitivas. Rev Neurol. 2011;52:725-42.

  8. Back SA. Cerebral white and gray matter injury in newborns: New insights into pathophysiology and management. Clin Perinatol. 2014 Mar;41(1):1–24. doi: 10.1016/j.clp.2013.11.001.

  9. Filippi C, Lin D, Tsiouris A, Watts R, Packard A, Heier L, et al. Diffusion-tensor MR imaging in children with developmental delay: preliminary findings. Radiology. 2003 Oct;229(1):44-50. Epub 2003 Aug 14.

  10. 10.Álvarez Sabin J, Mauriño Donato J. Lesiones de la sustancia blanca cerebral: significado clínico y mecanismos fisiopatológicos. Hipertensión. 2004;21(1):38-42.

  11. 11.Medrano Martorell S, Cuadrado Blázquez M, García Figueredo D, González Ortiz S, Capellades Font J. Imágenes puntiformes hiperintensas en la sustancia blanca: una aproximación diagnóstica. Radiología [Internet]. 2012 Jul-Ago [citado 4 Ago 2014];54(04): [aprox. 5 p.]. Disponible en: http://www.elsevier.es/es-revista-radiologia-119-articulo-imagenes-puntiformes-hiperintensas-sustancia-blanca-una-aproximacion-90148450

  12. 12.Pantoni L, García JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke. 1995;26:1293-301.

  13. 13.Bassi B, Vannelli S, Giraudo MC, Burdino E, Rigardetto R. Unidentified bright objects and neuropsychiatric disturbances. Minerva Pediatr. 2013 Aug;65(4):371-81.

  14. 14.Roman GC. From UBOs to Binswanger's disease: impact of magnetic resonance imaging on vascular dementia research. Stroke. 1996;27:1269-73.

  15. 15.Osborn AG. Angiografía cerebral. 2da ed. Madrid: Marbán Libros S.L; 2000.

  16. 16.Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis. Stroke. 1997;28:652-9.

  17. 17.Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41:450-4.

  18. 18.Kwee RM, Kwee TC. Virchow-Robin spaces at MR imaging. Radiographics. 2007;27 Jul-Aug;27(4):1071-86

  19. 19.Ramírez Navarro SV, Álvarez Rosell E, Paradela Ferrera C, Álvarez Ramírez E. Leucoaraiosis. Aspectos fisiopatológicos y diagnóstico por imagen. Rev Haban Cienc Méd [Internet]. 2013 Jul-Sept; [citado 5 Ene 2015];12(3): [aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2013000300006

  20. 20.Grueter EB, Schulz GU. Age-related cerebral white matter disease (Leukoaraiosis): a review. Postgrad Med J. 2012;88:79-87.

  21. 21.Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol. 2010;119:277-90.

  22. 22.Briley DP, Haroon S. ¿La Leucoaraiosis Predice la Morbilidad y la Mortalidad? Neurology. 2000 Ene;54:90-94.

  23. 23.O'Sullivan M, Lythgoe DJ, Pereira AC, Summers PE, Jarosz JM. Patterns of cerebral blood flow reduction in patients with ischemic Leukoaraiosis. Neurology. 2002;59:321-26.

  24. 24.Smith EE. Leukoaraiosis and stroke. Stroke. 2010;41:139-43.

  25. 25.Luia YW, Tanga ER, Allmendingerb AM, Spektorb V. Evaluation of CT Perfusion in the setting of cerebral ischemia: Patterns and pitfalls. AJNR. 2010;31:1552-63.

  26. 26.Appelman AP, Vincken KL, Van der Graaf Y. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study. Cerebrovasc Dis. 2010;29:28-35.

  27. 27.Smith R, Ropele S, Ferro J, Madureira S, Verdelho A. Diffusion-weighted imaging and cognition in the leukoaraiosis and disability in the elderly study. Stroke. 2010;41(5):402-8.

  28. 28.Ovbiagele B, Saber LJ. Cerebral white matter hyperintensities on MRI: Currents concepts and therapeutic implications. Cerebrovasc Dis. 2006;22 (2-3):83-90. Epub 2006 May 9.

  29. 29.Jiménez I, Agulla J, Pouso M, Sabucedo M, Rodríguez-Yánez M. Deterioro cognitivo asociado a la Leucoaraiosis: fisiopatología, manifestaciones clínicas y tratamiento. Rev Neurol. 2008;47(10):536-44.

  30. 30.O'Sullivan M. Leukoaraiosis. Pract Neurol. 2008;8:26-38.

  31. 31.Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-6.

  32. 32.Kenji Sudo F, Oliveira Alves CE, Sousa Alves G, Ericeira-Valente L, Tiel C, Madeira Moreira D, et al. White matter hyperintensities, executive function and global cognitive performance in vascular mild cognitive impairment. Arq Neuro-Psiquiatr [Internet]. 2013 Jul [citado 5 Ene 2015];71(7): [aprox. 4 p.]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2013000700431

  33. 33.Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new ratings cale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-22.

  34. 34.Barkhof F, Smithuis R, Multiple Sclerosis Radiology Assistant Website. Nombre del sitio [Internet]. 2013 [actualizado 13 May 2013; citado 15 Ene 2014]. Disponible en: http://www.radiologyassistant.nl/en/4556dea65db62

  35. 35.Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-9.

  36. 36.Black S, Gao F, Bilbao J. Understanding white matter disease. Imaging-pathological correlations in vascular cognitive impairment. Stroke. 2009 Mar;40(3 Suppl):S48-52.

  37. 37.Hazrati LN, Bergeron C, Butany J. Neuropathology of cerebrovascular diseases. Semin Diagn Pathol. 2009;26:103-15.

  38. 38.Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804-11.

  39. 39.Spilt A, Geeraedts T, de Craen AJ, Westendorp RG, Blauw GJ, van Buchem MA. Age-Related changes in normal-appearing brain tissue and white matter hyperintensities: more of the same or something else?. AJNR Am J Neuroradiol. 2005;26:725-9.

  40. 40.Spilt A, Goekoop R, Westendorp RG, Blauw GJ, de Craen AJ, van Buchem MA. Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. AJNR Am J Neuroradiol. 2006;27:1964-8.

  41. 41.Tanabe JL, Ezekiel F, Jagust WJ, Reed BR, Norman D, Schuff N, et al. Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol. 1999;20:839-44.

  42. 42.Ge Y, Law M, Herbert J, Grossman RI. Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. AJNR Am J Neuroradiol. 2005;26:2316-9.

  43. 43.Montalban X, Tintoré M, Swanton J, Barkhof F, Fazekas F, Filippi M, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427-34.

  44. 44.Rubio Rojas N, Miranda Quintana JA. Diagnóstico precoz de las enfermedades cerebrovasculares isquémicas. MEDISAN [Internet]. 2013 Nov [citado 5 Dic 2014];17(11): [aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192013001100015

  45. 45.Schneider JA, Wardlaw JM, Greenberg SM. Cerebral Microinfarcts: The Invisible Lesions. Lancet Neurol. 2012 Mar;11(3):272–82. doi: 10.1016/S1474-4422(11)70307-6.

  46. 46.Soontornniyomkij V, Lynch MD, Mermash S, Pomakian J, Badkoobehi H, Clare R, et al. Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol. 2010;20:459–67.

  47. 47.De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA, Pasquier F. The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol. 2011;18:1468–71.

  48. 48.Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar;42(3):722-7. doi: 10.1161/STROKEAHA.110.595082. Epub 2011 Jan 6.

  49. 49.Cordonnier C. Brain microbleeds. Prac Neurol. 2010;10:94-100.

  50. 50.Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41:1222–8.

  51. 51.Sueda Y, Naka H, Ohtsuki T, Kono T, Aoki S, Ohshita T, et al. Positional relationship between recurrent intracerebral hemorrhage/lacunar infarction and previously detected microbleeds. AJNR Am J Neuroradiol. 2010 Sept;31:1498-503.

  52. 52.Viswanathan A, Greenberg SM. Cerebral Amyloid Angiopathy in the Elderly. Ann Neurol. 2011 Dec;70(6):871–80. doi: 10.1002/ana.22516.

  53. 53.Donnan GA, Villemagne VL. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage. Neurology. 2010 Feb 9;74(6):487-93. doi: 10.1212/WNL.0b013e3181cef7e3.

  54. 54.Stojanov D, Aracki-Trenkic A, Vojinovic S, Ljubisavljevic S, Benedeto-Stojanov D, Tasic A, et al. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Bosn J Basic Med Sci. 2015 Feb;15(1):1–8.

  55. 55.Yoshimura S, Ago T, Koga M, Kamouchi M, Kitazono T. Cerebral Small-Vessel Disease in Neuro-Behçet Disease. J Stroke Cerebrovasc Dis 2015 Aug 27;24(8):e237-9. Epub 2015 Jun 27.

  56. 56.Choi JC. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy: a genetic cause of cerebral small vesels disease. J Clin Neurol. 2010;6(1):1–9.

  57. 57.Cabada Giadás M, Caballero Martínez C, Echávarri Zalba C, Solchaga Álvarez S, Bacaicoa Saralegui MC. Radiopathologic update on dementias: postmortem magnetic resonance. Radiología. 2010 Ene-Feb;52(01) :63/72 doi: 10.1016/j.rx.2009.09.005

  58. 58.Polman CH. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292–302.

  59. 59.Calabrese M, Favaretto A, Martin V, Gallo P. Grey matter lesions in MS. Prion. 2013 Jan 1;7(1):20–7.

  60. 60.Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S. Radiologically isolated syndrome–incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review. Mult Scler. 2013 Mar;19(3):271-80. doi: 10.1177/1352458512451943. Epub 2012 Jul 3.

  61. 61.Khoury M ND, Alsop DC, Agnihotri SP, Pfannl R, Wuthrich C, Ho ML. Hyperintense cortical signal on MRI reflects focal leukocortical encephalitis and seizure risk in PML. Ann Neurol. 2014 May;75(5):659–69.

  62. 62.Belvís Nieto R, Gracián García M. ¿Es realmente normal el cerebro de una persona con migraña entre los ataques?: Resonancia cerebral avanzada en migraña. Dolor: Investigación, clínica & terapéutica. 2015;30(1):29-42.

  63. 63.Canneti B, Mosqueira AJ, Gilo F, Carreras T, Meca L, Barbosa V, et al. Síndrome CLIPPERS con distribución atípica de las lesiones en la resonancia magnética cerebral. Rev Neurol. 2013;57(8):354-58.

  64. 64.Caminero AB, Sánchez Del Río González M. Migraña como factor de riesgo cerebrovascular. Neurología [Internet]. 2012 [citado 4 Dic 2014];27(02): [aprox. 5 p.]. Disponible en: http://www.elsevier.es/es-revista-neurologia-295-articulo-migrana-como-factor-riesgo-cerebrovascular-90118102

  65. 65.Jiménez FD. Cartier RL. Encefalopatía hepática fulminante vinculada a hiperintensidad de la corteza cerebral en la resonancia magnética. Rev Chil Neuro-Psiquiatr [Internet]. 2012 Mar [citado 5 Dic 2014];50(1): [aprox. 7 p.]. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717

  66. 66.McKinney AM, Lohman BD, Sarikaya B, Uhlmann E, Spanbauer J, Singewald T, et al. Acute hepatic encephalopathy: diffusion-weighted and fluid-attenuated inversion recovery findings, and correlation with plasma ammonia level and clinical outcome. AJNR Am J Neuroradiol. 2010;31(8):1471-9.

  67. 67.Toru S, Matumura K, Kawaguchi R, Kobayashi T, Irie T. Widespread cortical lesions on diffusion-weighted imaging in acute portal systemic shunt encephalopathy caused by primary biliary cirrhosis. AJNR Am J Neuroradiol. 2011;32(3):E55-6 Epub 2011 Jan 13.

  68. 68.McPhail M, Taylor-Robinson S. The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis. 2010;25:65-72.

  69. 69.Jiménez Arango JA, Uribe Uribe CS, Toro González G. Enfermedades menos conocidas de la mielina: lesiones desmielinizantes focales seudotumorales. Neurología [Internet]. 2015 Mar [citado 22 Abr 2015];30(02): [aprox. 8 p.]. Disponible en: http://www.elsevier.es/es-revista-neurologia-295-articulo-enfermedades-menos-conocidas-mielina-lesiones-90387875

  70. 70.Ferraz-Filho JR, da Rocha AJ, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino-Bertelli EC. Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities. Pediatric Radiology. 2012 Apr; 42(4):449-54.

  71. 71.Billiet T, Mädler B, D'Arco F, Peeters R, Deprez S, Plasschaert E, et al. Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis. Neuroimage Clin. 2014 Apr 13;4:649-58. doi: 10.1016/j.nicl.2014.04.005. eCollection 2014.




2020     |     www.medigraphic.com